OTCMKTS:MYMX Mymetics (MYMX) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free MYMX Stock Alerts $0.01 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.01▼$0.0150-Day Range$0.01▼$0.0152-Week Range$0.01▼$70.00VolumeN/AAverage Volume17 shsMarket Capitalization$1,500.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsStock AnalysisChartEarningsFinancialsSEC Filings Get Mymetics alerts: Email Address Ad DTIHow a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about About MymeticsMymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.Read More MYMX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MYMX Stock News HeadlinesMarch 29, 2024 | seekingalpha.comPLTXF PlantX Life Inc.February 2, 2024 | finance.yahoo.comMymetics Corporation (MYMXD) Stock Historical Prices & Data - Yahoo FinanceApril 26, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.December 31, 2023 | benzinga.comMymetics Stock (OTC:MYMX) Dividends: History, Yield and DatesMarch 1, 2023 | lse.co.ukOriole Resources project in Cameroon delivers high-grade gold resultsNovember 16, 2022 | benzinga.comMymetics Stock (OTC:MYMX), Short Interest ReportOctober 11, 2022 | finance.yahoo.comMymetics Corporation (MYMX)September 1, 2022 | seekingalpha.comMymetics, PCI Biotech team up for preclinical research on cancer therapyApril 26, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.September 1, 2022 | finanznachrichten.deMymetics Corporation: Mymetics and PCI Biotech Sign a Preclinical Research CollaborationAugust 31, 2022 | finance.yahoo.comMymetics and PCI Biotech Sign a Preclinical Research CollaborationAugust 25, 2022 | reuters.comMYMX.PK - Mymetics Corp | Stock Price & Latest News | ReutersSee More Headlines Receive MYMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mymetics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:MYMX CUSIPN/A CIK927761 Webwww.mymetics.com Phone(121) 653-4535Fax41-21-653-2473Employees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,060,000.00 Net Margins-1,914.40% Pretax Margin-1,917.46% Return on EquityN/A Return on Assets-128.84% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.08 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.23) per share Price / Book-0.04Miscellaneous Outstanding Shares150,000Free Float144,000Market Cap$1,500.00 OptionableNot Optionable Beta1.74 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Ronald Kempers (Age 56)CEO, COO, President & CFO Comp: $303.83kMr. Mario Amacker Ph.D.Head of Quality & ManufacturingKey CompetitorsGenocea BiosciencesNASDAQ:GNCARegeneRx BiopharmaceuticalsOTCMKTS:RGRXEndonovo TherapeuticsOTCMKTS:ENDVDMillennium Investment & AcquisitionOTCMKTS:MILCOncoSec MedicalNASDAQ:ONCSQView All Competitors MYMX Stock Analysis - Frequently Asked Questions How have MYMX shares performed in 2024? Mymetics' stock was trading at $0.0020 at the start of the year. Since then, MYMX shares have increased by 400.0% and is now trading at $0.01. View the best growth stocks for 2024 here. What other stocks do shareholders of Mymetics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Mymetics investors own include Genocea Biosciences (GNCA), Dynavax Technologies (DVAX), Fujitsu (FJTSY), Himax Technologies (HIMX), Maxar Technologies (MAXR), Revance Therapeutics (RVNC), Boeing (BA), Activision Blizzard (ATVI), Asure Software (ASUR) and Arlo Technologies (ARLO). How do I buy shares of Mymetics? Shares of MYMX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MYMX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mymetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
